CPhI Pharma IPR

CPhI's Pharma IPR event brings together IP Heads from pharma & biopharma and global law firms to discuss litigation&prosecution case laws in Pharma &Biopharma

[Giving Back @NGOIndia_UBM]

Find ur social calling wid #GivingBack #NGOIndia 2013 dat brings #NGOs & #corporates 2getther
http://t.co/ZgBCoIqxFZ

[Reshma Ramachandran @reshmagar]

.#SouthAfrican #pharma firms planning to delay patents law reform w/ @MSF_Access @lottirutter quoted http://t.co/ybjZA1Q7sO via @guardian

[Managing IP @ManagingIP]

.@IPAustralia is soliciting public comments on IP Laws Amendment Bill 2014: http://t.co/GPrFJJmTH3

[Tapan Ray @tapan_ray]

An Interesting News: Sanofi sets up centre to discover natural antibiotics http://t.co/GRGUHIIHsQ #pharma #IndiaPharma #healthcare

[CPhI Pharma IPR @CPhI_PharmaIPR]

Free download: Presentation on Overview of Medical Service Regime in Japan: http://t.co/rHyHCa9Lh1 #Pharma, #pharmapatents

[CPhI Pharma IPR @CPhI_PharmaIPR]

Sharing some of the highlights from Pharma IPR 2013. Click here to view the full video: http://t.co/d6OtBq2F9D.

[CPhI Pharma IPR @CPhI_PharmaIPR]

Glad to have @SpicyIP @ipwatch on board to support our 3rd Annual @CPhI_PharmaIPR conference. Know more here: http://t.co/dynSVCvdGU

[Joseph Ross @jsross119]

Lots of info on PhRMA companies with major drugs losing patent protection in 2014 via @BW; EliLilly faces steep cliff http://t.co/fiZJMrr5jU

[Tim Krupa @TimKrupaCA]

""It is a fairly groundbreaking decision," McTiernan said. "The big trend is that they want pharma companies to be... http://t.co/t0UoXR6JPS

[SAFPI @Safpi]

Emerging markets (Brazil, South Africa) initiate patent law reform in line with India’s IP policy http://t.co/a9x93qjb40 via @sharethis

[Pharma_newsnow @Pharma_newsnow]

The Op-Ed: What Patent Reform In Brazil And South Africa Can Mean http://t.co/QtH6lyhSEt

[Aaron Barkoff @orangebookblog]

PTAB Finds § 315(b) Barred Petition for Inter Partes Review Challenging Claims Amended in… http://t.co/ajgmluCn1a

[Aaron Barkoff @orangebookblog]

Cadence Prevails in OFIRMEV® (Acetaminophen) ANDA Litigation http://t.co/XAJ6pRSF2u

[Aaron Barkoff @orangebookblog]

Divided Federal Circuit Panel Strikes Down Galderma’s Patents as Obvious—in Shifting the… http://t.co/3hP6n3nLIe

[BioCentury @BioCentury]

Biosimilars in 2015? Usdin explains tie to expiration of blockbuster biotech drug patents. #BioCenturyTV http://t.co/Oe03NWEaiD

[Deborah (Question!) @cantata21]

Patents Against People: How Drug Companies Price Patients out of Survival | Dissent Magazine http://t.co/6g1UfVJhsK via @dissentmag

[Castan Centre for Human Rights Law @CastanCentre]

The #cancer divide: India's efforts to aid poor worry drug makers http://t.co/oMOX7VgSNy #IP #BigPharma #patents #India

[Ben Phillips @benphillips76]

Patents versus Patients, again! -> New York Times: India’s Efforts to Aid Poor Worry Drug Makers http://t.co/3CWSHkw8Uk